MAS
CVS icon

Meeder Advisory Services’s CVS Health CVS Stock Holding History

Meeder Advisory Services’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.6M Buy
22,249
+942
+4% +$72.6K 0.07% 204
2025
Q4 		$1.69M Buy
21,307
+2,408
+13% +$190K 0.07% 187
2025
Q3 		$1.42M Sell
18,899
-48
-0.3% -$3.29K 0.07% 205
2025
Q2 		$1.31M Sell
18,947
-1,260
-6% -$82.6K 0.07% 203
2025
Q1 		$1.37M Buy
20,207
+3,761
+23% +$225K 0.08% 196
2024
Q4 		$738K Sell
16,446
-1,192
-7% -$66.9K 0.05% 277
2024
Q3 		$1.11M Sell
17,638
-1,080
-6% -$63K 0.07% 217
2024
Q2 		$1.11M Buy
18,718
+4,161
+29% +$260K 0.08% 202
2024
Q1 		$1.16M Buy
14,557
+926
+7% +$70.7K 0.12% 150
2023
Q4 		$1.08M Sell
13,631
-93
-0.7% -$6.62K 0.12% 143
2023
Q3 		$958K Sell
13,724
-3,313
-19% -$235K 0.12% 143
2023
Q2 		$1.18M Sell
17,037
-1,064
-6% -$75.7K 0.13% 139
2023
Q1 		$1.35M Sell
18,101
-2,972
-14% -$249K 0.16% 112
2022
Q4 		$1.96M Buy
+21,073
New +$2.03M 0.25% 75

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Meeder Advisory Services's CVS Position: Q1 2026 in Review

Meeder Advisory Services increased its CVS Health (CVS) stake by 4.4% in Q1 2026, buying an estimated $72.6K and bringing the position to 22,249 shares worth $1.6M. The position accounts for 0.07% of the portfolio, ranked #204.

Meeder Advisory Services first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.96M in Q4 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Meeder Advisory Services held 22,249 shares of CVS Health worth $1.6M as of Q1 2026.
  • Meeder Advisory Services bought 942 CVS Health shares in Q1 2026, an estimated $72.6K.
  • CVS Health made up 0.07% of Meeder Advisory Services's portfolio in Q1 2026, its #204 holding.
  • Meeder Advisory Services first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's CVS Health position peaked at $1.96M in Q4 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.